Stakeholders
EQIPD actively involves stakeholders – from leading research organizations but also funders and publishers – in order to collect and understand needs and expectations, current best practices and challenges.
- Alexander Dityatev, Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
- Alicia Faruzzi Brantley, Scripps FL
- Andreas Scherer, Institute for Molecular Medicine Finland (FIMM)
- Anne-Charlotte Fauvel, European Infrastructure for Translational Medicine (EATRIS)
- Anne-Laure Bonnefont, Institut national de la santé et de la recherche médicale (INSERM U1183)
- Annik Leyman, Universiteit Gent
- Arnoud Herremans, Y47
- Ben Fitzpatrick, Tempest Technologies
- Bernard Lerer, Hadassah – Hebrew University Medical Center
- Bruce O’Hara, University of Kentucky (UKY)
- Chantelle Ferland-Beckham, Cohen Veterans Bioscience
- Christina Dalla, National and Kapodistrian University of Athens (NKUA)
- Claudia Pitzer University of Heidelberg (UHEI)
- David McKinzie, Indiana University
- Elsa Pioli, Motac Neuroscience Ltd (Motac)
- Eric M. Prager, Wiley
- Ernesto Prado Montes de Oca, Personalized Medicine National Laboratory (LAMPER), Medical and Pharmaceutical Biotechnology, Guadalajara Unit, CIATEJ A.C.
- Frank Hughes, Tietronix Software
- Frank Thadewaldt, Enso Software GmbH
- Gerald M. Herrera, Med Associates Inc.
- Igor Branchi, Instituto Superiore di Sanità
- Ioannis Sotiropoulos, University of Minho
- Irina V. Belozertseva, Pavlov Med Uni
- Janko Samardzic, University of Belgrade
- Jean Claude Dorego, Université de Rouen Normandie (UNIV ROUEN)
- Jean Luc Dorego, Université de Rouen Normandie (UNIV ROUEN)
- John Kroehle, Jr., Data Sciences International Inc.
- Jonathan Ward, ETH Zuerich
- Jos Prickaerts, Univeristy Maastricht
- Judith Homberg,Radboud Universität, Nijmegen Medical Centre (RUMC)
- Karine Cambon, Institut François Jacob/ MIRCen
- Ken Drake, Seralogix
- Lawrence Moon, King’s College London
- Leonardo Restivo, Lausanne University
- Lior Bikovski, Tel Aviv University (TAU)
- Lucianne Groenink, Utrecht University
- Magali Dumont, ICM-Hôpital Pitié-Salpêtrière (ICM)
- Magali Haas, Cohen Veterans Bioscience
- Marianne Kordel, Deutsches Zentrum für Luft- und Raumfahrt (DLR)
- Martin de Kort, European Infrastructure for Translational Medicine (EATRIS)
- Matt McLoughlin, Scientist.com
- Michael Curtis, King’s College London (KCL)
- Michael Schunn, Institute of Science and Technology
- Michael Tsoory, Weizmann Institute of Science (Weizmann)
- Natasja de Bruin & Martine Hoffmann, Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie (Frauenhofer IME)
- Olivier Blin, Pharmacologie clinique – Hôpital de la Timone (La Timone)
- Osvalds Pugovics, The Latvian Institute of Organic Synthesis
- Paul Moser, CERBASCIENCE EIRL
- Piotr Popik, Institute of Pharmacology Polish Academy of Sciences (IF-PAN)
- Raafat Farés, Etisense SAS
- Sabine Hölter, Helmholtz Zentrum München, Institute of Developmental Genetics (IDG)
- Sara Wells, Medical Research Council (MRC UK)
- Simon Loiodice, Biotrial
- Stacey Rizzo, The Jackson Laboratory (JAX)
- Stefanie van der Burght, Universiteit Gent
- Sylvia Badurek, Vienna Biocenter Core Facilities GmbH (VBCF),
- Thomas van Groen, The University of Alabama at Birmingham (UAB)
- Todd Sherer, The Michael J. Fox Foundation
- Valérie Bertaina-Anglade, Biotrial
- Valerie Gailus-Durner, Helmholtz Zentrum München, Institute of Experimental Genetics (IEG)
- Vootele Voikar, Helsinki University
If you would like to join, please contact us.